Psilocybin: Capturing Brain Mechanisms of Motivation and Neurocognition in Individuals With Opioid Use Disorder

Phase: PHASE2 | Sponsor: Anna Rose Childress, Ph.D. | Compound: Psilocybin

Status

recruiting

Institution

Anna Rose Childress, Ph.D.

Start date

2025-11-01

End date

2026-05-01

Registry ID

NCT06810310

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.